Professional Summary

Professional Overview

Philip Ottiger is the President and CEO of Bachem America Inc, a leading global pharmaceutical company specializing in the development and manufacture of peptides and oligonucleotides. With extensive expertise in the pharmaceutical industry, Ottiger brings a strategic and results-oriented approach to driving the company's growth and innovation.

Current Role

As President and CEO, Ottiger is responsible for overseeing the overall strategic direction and day-to-day operations of Bachem America. He is focused on expanding the company's market presence, strengthening its research and development capabilities, and fostering a culture of excellence and continuous improvement. Under his leadership, Bachem America has maintained its position as a trusted partner for pharmaceutical and biotech companies worldwide.

Career Progression

Ottiger's career in the pharmaceutical industry spans over two decades, during which he has held progressively senior roles. Prior to joining Bachem America, he served as the Vice President of Operations at a leading contract manufacturing organization, where he was instrumental in driving operational efficiencies and enhancing the company's service offerings.

Academic Background

Ottiger holds a Bachelor's degree in Chemical Engineering from the University of California, Los Angeles (UCLA) and a Master's degree in Business Administration from the University of Southern California (USC).

Areas of Expertise

Ottiger's areas of expertise include pharmaceutical manufacturing, supply chain management, strategic planning, and organizational leadership. He is known for his ability to navigate complex regulatory environments, foster collaborative partnerships, and drive continuous improvement initiatives.

Professional Impact

Under Ottiger's leadership, Bachem America has consistently delivered high-quality products and exceptional customer service, strengthening its reputation as a reliable and innovative partner in the pharmaceutical industry. He has also been actively involved in industry associations, contributing to the advancement of best practices and advocating for the continued growth and development of the peptide and oligonucleotide sectors.

Conclusion

With his extensive industry experience, strategic vision, and commitment to excellence, Philip Ottiger is well-positioned to guide Bachem America's ongoing success and drive further innovation in the pharmaceutical industry.